These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36985814)

  • 21. Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis.
    Rodrigues MP; Tomaz DC; Ângelo de Souza L; Onofre TS; Aquiles de Menezes W; Almeida-Silva J; Suarez-Fontes AM; Rogéria de Almeida M; Manoel da Silva A; Bressan GC; Vannier-Santos MA; Rangel Fietto JL; Teixeira RR
    Eur J Med Chem; 2019 Dec; 183():111688. PubMed ID: 31542714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-circulation of Toscana virus and Leishmania infantum in a focus of zoonotic visceral leishmaniasis from Central Tunisia.
    Fares W; Dachraoui K; Barhoumi W; Cherni S; Chelbi I; Zhioua E
    Acta Trop; 2020 Apr; 204():105342. PubMed ID: 31954137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
    Allahverdiyev AM; Abamor ES; Bagirova M; Baydar SY; Ates SC; Kaya F; Kaya C; Rafailovich M
    Exp Parasitol; 2013 Sep; 135(1):55-63. PubMed ID: 23792003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of BTK Inhibitor Ibrutinib on Leishmania infantum Infection In Vitro.
    Mert U; Müftüoğlu C; Erdem S; Sadıqova A; Toz S; Ozbel Y; Caner A
    Acta Parasitol; 2022 Dec; 67(4):1732-1739. PubMed ID: 36260194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation, typing, and drug susceptibility of Leishmania (Leishmania) infantum isolates from dogs of the municipality of Embu das Artes, an endemic region for canine leishmaniasis in Brazil.
    Ferreira BA; Martins TFC; Coser EM; da L Oliveira V; Yamashiro-Kanashiro EH; Rocha MC; Pinto MM; Cotrim PC; Coelho AC
    Parasitol Res; 2022 Sep; 121(9):2683-2695. PubMed ID: 35802163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.
    Tejería A; Pérez-Pertejo Y; Reguera RM; Carbajo-Andrés R; Balaña-Fouce R; Alonso C; Martin-Encinas E; Selas A; Rubiales G; Palacios F
    Eur J Med Chem; 2019 Jan; 162():18-31. PubMed ID: 30408746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antileishmanial activity of H1-antihistamine drugs and cellular alterations in Leishmania (L.) infantum.
    de Melo Mendes V; Tempone AG; Treiger Borborema SE
    Acta Trop; 2019 Jul; 195():6-14. PubMed ID: 31002807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New diarylsulfonamide inhibitors of Leishmania infantum amastigotes.
    González M; Alcolea PJ; Álvarez R; Medarde M; Larraga V; Peláez R
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():45-64. PubMed ID: 34015753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition.
    Istanbullu H; Bayraktar G; Karakaya G; Akbaba H; Perk NE; Cavus I; Podlipnik C; Yereli K; Ozbilgin A; Debelec Butuner B; Alptuzun V
    Eur J Med Chem; 2023 Feb; 247():115049. PubMed ID: 36577215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes.
    Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA
    Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antileishmanial activity evaluation of thiazolidine-2,4-dione against Leishmania infantum and Leishmania braziliensis.
    Neri FSM; Júnior DBC; Froes TQ; da Silva PBG; do Egito MS; Moreira POL; de Pilla Varotti F; Castilho MS; Teixeira-Neto RG; de Albuquerque JFC; Leite FHA
    Parasitol Res; 2020 Jul; 119(7):2263-2274. PubMed ID: 32462293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil.
    Lara-Silva Fde O; Michalsky ÉM; Fortes-Dias CL; Fiuza Vde O; Pessanha JE; Regina-Silva S; de Avelar DM; Silva MA; Lima AC; da Costa AJ; Machado-Coelho GL; Dias ES
    Acta Trop; 2015 Aug; 148():128-36. PubMed ID: 25882769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.
    de Jesus JA; Laurenti MD; Antonangelo L; Faria CS; Lago JHG; Passero LFD
    J Immunol Res; 2021; 2021():6671287. PubMed ID: 33681389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High molecular prevalence of Leishmania in phlebotomine sand flies fed on chicken blood in Brazil.
    de Sousa Ferreira T; Timbó RV; Minuzzi-Souza TTC; de Almeida Rocha D; Neiva M; de Albuquerque Ribeiro J; de Almeida PS; Hecht M; Nitz N; Gurgel-Gonçalves R
    Vet Parasitol; 2018 Aug; 259():80-84. PubMed ID: 30056989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
    Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
    Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
    Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
    Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.